Nanotechnology and Advanced Materials Department, Materials and Energy Research Center, Karaj, Iran.
Nanotechnology and Advanced Materials Department, Materials and Energy Research Center, Karaj, Iran.
Int J Biol Macromol. 2022 Jul 1;212:165-171. doi: 10.1016/j.ijbiomac.2022.05.125. Epub 2022 May 21.
In this work, the extraction of carboxylated nanocrystalline cellulose from oat husk as an agricultural waste was conducted by ammonium persulfate oxidation. This is a one-step and efficient process for removal of amorphous regions from cellulosic fibers. The mean size of cellulose nanoparticles is about 30 nm with spherical morphology. The comparison of the infrared spectrum of the nanoparticles of cellulose and the primary oat husk evidences the successful elimination of non-cellulosic structures such as hemicellulose, lignin in nanocellulose sample. The X-ray diffraction patterns show higher degree of crystalline index in nanocellulose (57%) compared to the primary oat husk (38%). The comparison of the onsets of temperature degradation of the samples shows nanocellulose is less thermally stable than oat husk. The hydrophilic surface of the nanocellulose was modified using cetyltrimethylammonium bromide (CTAB) cationic surfactant to improve loading capacity of hydrophobic indomethacin drug which has a low bioavailability and poor solubility in water. In vitro release profile of the indomethacin and drug release mechanism was studied. The results show the 67% of drug is released within 12 h and CTAB modified nanocellulose greatly acts as an indomethacin controlled-release carrier. Study of the in vitro drug release kinetics shows driven mechanism is diffusion-controlled release.
在这项工作中,通过过硫酸铵氧化从燕麦壳这种农业废弃物中提取羧基化纳米纤维素。这是一种从纤维素纤维中去除无定形区域的一步法和有效工艺。纤维素纳米颗粒的平均粒径约为 30nm,呈球形形态。纳米纤维素和原燕麦壳的红外光谱比较证明了非纤维素结构(如半纤维素、木质素)在纳米纤维素样品中已被成功去除。X 射线衍射图谱表明,与原燕麦壳(38%)相比,纳米纤维素的结晶度指数(57%)更高。对样品起始温度降解的比较表明,纳米纤维素的热稳定性不如燕麦壳。使用十六烷基三甲基溴化铵(CTAB)阳离子表面活性剂对纳米纤维素的亲水表面进行改性,以提高疏水性吲哚美辛药物的载药量,吲哚美辛药物的生物利用度低,在水中溶解度差。研究了吲哚美辛的体外释放曲线和药物释放机制。结果表明,67%的药物在 12 小时内释放,CTAB 改性纳米纤维素可作为吲哚美辛的控释载体。体外药物释放动力学研究表明,驱动机制是扩散控制释放。